In this study, we identified IKZF1 mutations/deletions (6%) as an independent risk factor for worse EFS and RFS in AML patients with CEBPAbZIP-inf mutations, which has rarely been reported. This evidence concerns the gene IKZF1 and acute myeloid leukemia.